Ad copy

I don't give a f*ck if this upsets you. I am going to say something that nobody with Type 2 diabetes wants to hear. I've treated Type 2 diabetes in Switzerland for 18 years without putting my patients on Metformin. When I moved to America, I couldn't believe what doctors here were telling diabetic patients. I moved to the United States two years ago when my husband's company transferred him to Chicago. I joined a family medicine practice here. Good practice. Good doctors. And in my first three months, I saw something that kept me up at night. Men and women in their 50s and 60s walking into my office already on four, five, six medications. Metformin. A blood pressure pill. A statin. Sometimes a water pill. Sometimes a second blood pressure pill layered on the first. And now their previous doctor was telling them they needed a seventh — a GLP-1 shot or insulin — because the number had crept up again despite full compliance. Nobody had ever explained what any of the pills were actually doing. Nobody had told them every one of those bottles was addressing a downstream measurement while the upstream failure that made all of them necessary had never been touched. And ten years into this arrangement, they were sitting in my office with tingling feet, protein leaking into their urine, vision blurring in the afternoons, and liver enzymes drifting upward on every panel. Every one of them said the same thing. My doctor says my A1C is well-controlled. He added a medication whenever the number climbed. He's monitoring the complications. Monitoring them. In Switzerland, we don't monitor diabetic complications while stacking prescriptions that cannot address the barrier producing them. We open the barrier. Because by the time a patient is on four medications, the pharmaceutical intervention itself has become a full-time management project — and the mechanism that made the first prescription necessary is still running behind every pill added since. Here is what your doctor has probably not told you about why the medications keep multiplying. Type 2 diabetes is not really a blood sugar problem. The blood sugar is the symptom. The real problem is that after years of constant carbs and elevated insulin, the doors on your cells — the GLUT4 transporters that are supposed to open when insulin knocks and pull glucose out of your blood — stop responding to the signal. Insulin arrives. The doors do not open. Your pancreas sends more insulin. Still nothing. The glucose has nowhere to go. It stays in your blood. Trapped. Every medication in your regimen is managing one downstream expression of that failure. Metformin tells your liver to make less new sugar. Reduces the supply. Your A1C drops. Your doctor is happy. But the glucose already trapped in your blood is still trapped. The drug never touched the doors. Then your blood pressure climbs. Not from salt. Not from stress. From the same trapped sugar stiffening your arterial walls. So they add a blood pressure pill. It relaxes the vessels. It does not repair them. Then your cholesterol climbs. Not from what you ate. From insulin resistance driving your liver to overproduce lipids. So they add a statin. It reduces cholesterol synthesis. It does not address the signal telling the liver to overproduce in the first place. Then your kidneys start showing strain. Because the trapped sugar has been grinding through the small filters for years while every drug you were on managed a different number. So they add a water pill. Or a second blood pressure medication. Or they float the idea of an SGLT2 inhibitor. Each drug addresses one downstream measurement. The upstream failure — the GLUT4 doors that stopped responding — continues running behind every prescription. The prescriptions keep the individual numbers in a range the system calls managed. They do not interrupt the process producing the numbers. So the pills accumulate. Peer-reviewed endocrinology research has documented for years that cellular insulin resistance, not insufficient insulin, is what drives chronic Type 2 progression in patients with otherwise perfect compliance. Not poor diet. Not laziness. Not inconsistency. Cellular insulin resistance. Your compliance isn't the problem. The protocol treating your pill count as the solution is. Another thing I see is the trendy GLP-1 shots. I want to be honest about those, because most of my American patients have been asking about them. Ozempic. Mounjaro. Wegovy. Some have already been on them. GLP-1s slow how fast your stomach empties so less sugar enters your blood after a meal. They suppress appetite. Some patients see real weight loss. What they cannot do is open the cellular doors that have stopped responding to insulin. The trapped sugar is still trapped. The insulin resistance is still running. And the lawsuits stacking up against them right now — gastroparesis, sarcopenia, bone density loss — are real problems showing up in people who took the shots and trusted they were safe. They are another downstream drug for the same upstream failure. I've watched patients start a GLP-1 with a real initial response, lose weight, feel better. Twelve months later they come off, and the appetite comes back, the weight comes back, and the trapped sugar that was there before the shot is still there. Because nothing about the underlying receptor dysfunction was ever repaired. This is what nobody tells you about where the cascade leads. The pill count does not stay stable. It grows. One drug becomes two. Two become four. Four become six. The last stop before insulin injections is a medicine cabinet that looks exactly like your parent's did at the same age. I've had this conversation more times than I should have. With patients who did everything their previous doctor told them. Who took every pill. Who added the next one when it was offered. Whose A1C stayed managed year after year while their kidneys quietly declined, their nerves quietly died, and their next appointment came with another prescription. The Metformin managed the supply. The statin managed the cholesterol. The blood pressure pill managed the pressure. The trapped sugar underneath kept advancing. Silently. Systematically. Until the pill count reached six and the only conversation left was insulin. When I arrived in the US, I assumed the research on cellular insulin reactivation simply hadn't made it here yet. In Switzerland, we'd been working with insulin-mimetic protocols for over a decade. It emerged from European metabolic research in the early 2010s. Clinicians studying why some Type 2 patients responded to Metformin and others kept progressing despite identical protocols. What we found was that the non-responders had significantly more advanced cellular insulin resistance. The Metformin could not open the doors. Only address the supply. It wasn't drug failure. It was barrier failure. That research led to studies on whether opening the cellular doors directly — with insulin-mimetic compounds, specifically MHCP from true Ceylon cinnamon and cinnamaldehyde from the same spice — could reverse the underlying disease without stacking more prescriptions. Published research in Diabetes Care documented MHCP directly reactivating the cellular doors that had stopped responding to insulin. It activates the same metabolic pathways exercise activates. It moves glucose into cells without relying on the broken insulin signal. It shuts down the NLRP3 inflammasome — the master switch behind chronic metabolic inflammation. Cinnamaldehyde reduces the oxidative stress that has been damaging your blood vessels for years. It isn't forcing anything. It is removing the interference. And when the interference is removed, the pill count stops climbing. I want to tell you about one patient. Because his results are what I see when the barrier finally gets addressed. He was 62. Type 2 diabetic for nine years. A1C 7.4. Fasting glucose 178. On Metformin twice daily. On Lisinopril for the blood pressure that climbed at year four. On a statin added at year six. On a water pill added at year eight for the kidney strain his previous doctor said we should keep an eye on. Four pills. Every morning. Every night. The next appointment was about starting a fifth — a GLP-1 shot — because his A1C had climbed from 7.0 to 7.4 despite full compliance. He came to me for a second opinion. His compliance was perfect. The disease was real. His feet were tingling. His vision was blurring after lunch. His creatinine had been drifting upward for two years. But he wasn't okay with a fifth prescription. His father had ended up on seven. His father had started insulin at 71. His father had lost his left foot at 74. He could see exactly where the line led because he had watched someone walk it all the way to the end. In Switzerland, before we ever escalate to a fifth prescription, we ask one question. What is actually happening in the cells? Metformin reduces the supply. The blood pressure pill relaxes the vessels. The statin reduces the cholesterol. Not one of them opens the doors. I recommended 90 days of cellular insulin reactivation before making any further medication decisions. He was skeptical. Nine years of perfect compliance across four medications had not moved his A1C below the high 6s. He did not believe a spice could change what nine years of medication had not. I explained it simply. Every drug you are on is addressing one measurement. None of them is opening the doors. Your numbers stopped moving because the doors are still closed and the trapped sugar still has nowhere to go. You can turn down the tap in four different ways. If the drain is still clogged, the water does not drain. He agreed to try. I told him I would not recommend buying anything until I had looked at it myself. That is how I was trained in Zurich. You do not put your name behind a supplement the way you would not put your name behind a medication. You verify the source. You read the lab work. You confirm the patient is taking what the label says. I went looking that afternoon. Most of what I found was useless. The majority of cinnamon sold in the US is not true Ceylon. It is Cassia — Cinnamomum cassia — a completely different tree from China. The compounds your cells actually need to respond to are barely present in it. And Cassia contains coumarin, a compound documented as toxic to the liver at daily doses. The European Food Safety Authority flagged this years ago. As little as a quarter teaspoon a day pushes daily coumarin intake past the safe limit. So the cheap cinnamon most diabetics buy on Amazon to support their blood sugar is quietly stressing the organ they are trying to protect. And even when I found real Ceylon, it was usually in dry capsule or powder form. Which is also a problem. The active compounds in cinnamon — MHCP and cinnamaldehyde — are fat-soluble. They need a fat carrier to cross the intestinal membrane and enter the bloodstream. A dry powder or capsule has no carrier. The compounds reach the gut, find nothing to transport them across the wall, and pass straight through. I needed a brand that had real Ceylon, DNA-verified at the species level, concentrated to match the clinical trial doses, and suspended in a fat that could actually deliver it. I found one. Metabolae. I called the company directly before I recommended it to a single patient. I asked for the Certificate of Analysis. I asked for the DNA verification. I asked about the concentration and the carrier oil. I asked about coumarin levels. They sent me everything within the day. DNA-verified Cinnamomum verum, sourced directly from Sri Lanka. Concentrated 12 to 1 to match the dosing range in the published research — 7,200mg equivalent per softgel. Suspended in organic MCT oil, which is the carrier the compounds need to cross the cell wall. Third-party tested. Coumarin levels confirmed safe for daily long-term use. Made in the USA. That is the brand I recommended to him. One softgel with breakfast. That is the whole protocol. No fifth prescription. Week 1. Steady energy through the afternoon. The 2 PM crash he had been living with for years quieted within four days. Sleeping through the night for the first time in longer than he could remember. Week 2. Cravings quiet. The 3 AM wake-ups stopped. He came in and told me he had forgotten what it felt like to wake up rested. Week 4. Fasting glucose dropped from 178 to 112. The brain fog he had accepted as aging was clearing. The tingling in his feet was already easing. Week 12. A1C came back at 5.9. His blood pressure had come down enough that his previous doctor reduced the Lisinopril dose. His creatinine had drifted back from 1.3 to 1.1. His vision had stopped blurring after meals. The next conversation with his previous doctor was not about adding a fifth prescription. It was about removing one. The doors had opened. The trapped sugar was moving. Insulin sensitivity was restoring. No further medication needed. Six months in, the statin conversation had shifted. His lipid panel had improved to a point where his previous doctor was open to a trial off it. The water pill came off first. His pill count had gone from four and climbing to two and decreasing — for the first time since his diagnosis nine years ago. The cascade had reversed direction. In Switzerland, this is where we start. Not with the fifth prescription. With the doors. I share this because I have spent two years quietly frustrated by what I see here. Patients who came to me on four, five, six medications and could not tell me what any of them were doing. Patients who felt like they were failing. Like their bodies were betraying them despite perfect compliance across a growing prescription stack. They weren't failing. The protocol treating their pill count as the solution was failing them. American primary care training focuses on adding a medication when a number climbs. Insulin-mimetic protocols — addressing the actual cellular barrier — are not part of standard training here. Most American physicians graduated before this research was emphasized. They practice what they were taught. That is not a criticism. It is simply where the knowledge gap sits. But the research exists. And you do not have to wait for your doctor to find it. If you have been on Metformin for years and your A1C is creeping up. If you have already added a blood pressure pill or a statin and your previous doctor is preparing to add the next one. If you have watched a parent walk this same cascade all the way to insulin, or worse. The answer is not the next prescription. It is opening the cellular doors your prescriptions were never designed to reach. I will leave a link below to the product I recommend to my own patients. I have no financial relationship with this company. I recommend it because the mechanism is sound, the research supports it, and I have seen it work. You have spent years doing what you were told. It is time to address what you were never told. 90-day money-back guarantee. One softgel with breakfast. No prescription. Your body is not failing you. The protocol treating your prescription count as the answer is what is failing you. The trapped sugar is the barrier. Open the doors. — Dr. Caroline Moore, MD, Primary Care